Lawsuits have been filed alleging a link between the drug Dupixent and the development of T-cell lymphoma, a type of cancer. The lawsuits claim that the manufacturer failed to adequately warn about this potential side effect. Some of these lawsuits have been consolidated, with allegations including that Dupixent caused or accelerated the progression of T-cell lymphoma in some patients.